<DOC>
	<DOCNO>NCT01354704</DOCNO>
	<brief_summary>The objective study : Objective ultrasound : Determine presence absence subclinical DVT practice ultrasound-Doppler Day7 Day35 , patient underwent TKA THA Clinical objective To evaluate efficacy tolerability clinical Enox ® patient compare original drug Lovenox ® .</brief_summary>
	<brief_title>Echo-Doppler Assessment Occurrence Asymptomatic DVT Orthopedic Replacement Surgery Under Enoxaparin</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>man woman age 18 year , admit undergo orthopedic total knee total hip prosthesis require use enoxaparin 4000 IU Prophylaxis . Patient participate another study . hypersensitivity enoxaparin sodium , heparin unfractionated heparin low molecular weight . Patients risk major bleed uncontrolled include patient recent stroke Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>deep veinous thrombosis</keyword>
	<keyword>enoxaparin</keyword>
</DOC>